This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Medtronic (MDT) Initiates ONYX ONE- Clear Study on DAPT
by Zacks Equity Research
Following a DAPT interruption at one month on patients with a next generation DES, the Onyx ONE Clear Study by Medtronic (MDT) investigates risk of cardiac death, heart attack and stent thrombosis.
5 Health Care ETFs Outperforming XLV on YTD Basis
by Zacks Equity Research
Health care ETFs provide handsome returns year to date.
Medtronic (MDT) Grows on CRHF Arm, Margin Pressure Ails
by Zacks Equity Research
Solid demand for Medtronic's (MDT) quadripolar cardiac resynchronization therapy-pacemakers (CRT-P) along with growth in Mechanical Circulatory Support drives Heart Failure division revenues.
The Zacks Analyst Blog Highlights: Medtronic, EOG Resources, CSX, Analog Devices and Autodesk
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Medtronic, EOG Resources, CSX, Analog Devices and Autodesk
Top Stock Reports for Medtronic, EOG Resources & CSX Corporation
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Medtronic (MDT), EOG Resources (EOG) and CSX Corporation (CSX).
Company News For Aug 22, 2018
by Zacks Equity Research
Companies In The News are: COTY,MDT,SJM,TJX
Medtronic (MDT) Surges: Stock Moves 5.7% Higher
by Zacks Equity Research
Medtronic (MDT) was a big mover last session, as the company saw its shares rise more than 5% on the day amid huge volumes.
Medtronic (MDT) Q1 Earnings Beat on Growth in All Lines
by Zacks Equity Research
All major business groups of Medtronic (MDT) contribute to solid top-line growth at CER, which highlighted sustainability across groups and regions.
Medtronic (MDT) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Medtronic (MDT) delivered earnings and revenue surprises of 5.41% and 2.15%, respectively, for the quarter ended July 2018. Do the numbers hold clues to what lies ahead for the stock?
Will Strong RTG Arm Shape Medtronic's (MDT) Q1 Earnings?
by Zacks Equity Research
Medtronic (MDT) poised to gain on continued growth in RTG business in Q1.
Will Solid Diabetes Arm Drive Medtronic's (MDT) Q1 Earnings?
by Zacks Equity Research
Medtronic (MDT) poised to gain on strength in Diabetes business in Q1 on continued uptake of MiniMed 670G system in the United States along with enhanced sensor supply capacity.
Will Medtronic (MDT) Q1 Earnings Show Overall Progress?
by Zacks Equity Research
In Q1, Medtronic (MDT) is expected to have sustained a steady market share across the core pacing, ICD and CRT product lines.
Cardinal Health Product Spectrum Broad, Competition Rife
by Zacks Equity Research
Cardinal Health's (CAH) strategic buyouts lend it a competitive edge; the Cordis unit lacks luster.
Medtronic Launches IN.PACT Admiral in Japan, Boosts APV Arm
by Zacks Equity Research
Medtronic's (MDT) recent launch of IN.PACT Admiral DCB in Japan is expected to boost the top line.
Medtronic Unveils Inner CircleSM Program, Boosts Diabetes Arm
by Zacks Equity Research
Medtronic (MDT) focuses on initiatives to boost its diabetes business.
Becton, Dickinson Global Foothold Strong, Recalls Rampant
by Zacks Equity Research
Becton, Dickinson (BDX) gains from solid global foothold in Q3; foreign exchange headwinds raise concern.
United Therapeutics (UTHR) Q2 Earnings Flat Y/Y, Shares Dip
by Zacks Equity Research
United Therapeutics (UTHR) reports unimpressive second-quarter earnings. Sales rise sequentially. Shares sink 5%.
Medtronic (MDT) Rides on Innovation, Rising Costs a Woe
by Zacks Equity Research
Medtronic (MDT) continues to meaningfully accelerate all its three fundamental growth strategies, namely therapy innovation, globalization and economic value.
Is Medtronic (MDT) a Great Stock for Value Investors?
by Zacks Equity Research
Let's see if Medtronic (MDT) stock is a good choice for value-oriented investors right now from multiple angles.
Polaris, 58.com, BlackRock, Intuitive Surgical, Medtronic and NuVasive as Zacks Bull and Bear of the Day
by Zacks Equity Research
Polaris, 58.com, BlackRock, Intuitive Surgical, Medtronic and NuVasive as Zacks Bull and Bear of the Day
3 Stocks to Tap the Minimally-Invasive Surgery Market Boom
by Sweta Jaiswal
Consider these three stocks in the rapidly-growing minimally-invasive surgical device market.
New Indication for Medtronic's Bone Cement Gets 510(K) Nod
by Zacks Equity Research
Medtronic (MDT) to broaden its commitment to the therapy of pathological fractures of the vertebral body on the back of its expanded indication for Kyphon HV-R Bone Cement.
Medtronic Gets Expanded FDA Nod for MiniMed 670G System
by Zacks Equity Research
Medtronic (MDT) continues to adopt initiatives to bolster the Diabetes segment.
Tap Cardiovascular Devices Market Boom With These 3 Stocks
by Sweta Jaiswal
Consider these three stocks in the rapidly-growing cardiovascular devices market.
Medtronic's Expanded IN.PACT Admiral FDA Nod to Aid APV Arm
by Zacks Equity Research
Medtronic's (MDT) receipt of FDA approval for 200mm and 250mm lengths of the IN.PACT Admiral Drug-Coated Balloon (DCB) is expected to boost the top line.